Pioneering Cancer Care: Sarvodaya's Revolutionary Therapies
Sarvodaya Hospital in Faridabad is the first in India to offer Terbium-161 PSMA therapy for prostate cancer. The hospital also introduces CAR-T Cell therapy for blood cancers. These advancements position Sarvodaya as a leader in cancer care, providing comprehensive treatment from diagnosis to advanced therapy.
- Country:
- India
Sarvodaya Hospital in Faridabad, Delhi NCR, has become the first in India to offer Terbium-161 PSMA therapy for prostate cancer treatment. The introduction of this advanced nuclear medicine underscores the hospital's commitment to pioneering cancer care advancements.
The hospital has also launched CAR-T Cell therapy for blood cancers, including leukemia, lymphoma, and multiple myeloma. This positions Sarvodaya at the forefront of cancer treatment, combining innovative therapies to offer comprehensive care under one roof.
Led by Dr. Swagat Dash and Dr. Dinesh Pendharkar, the hospital's efforts reflect a significant leap in precision oncology. Sarvodaya Healthcare, with its extensive facilities and cutting-edge treatments, continues its commitment to delivering exceptional medical care to the community.
ALSO READ
-
Nuclear Science Brings Cancer Care, Safer Food and Better Water Data Across Regions
-
From Cancer Care to Nuclear Careers, IAEA Conference Puts Global Progress in Focus
-
IAEA and IDB Join Forces to Expand Nuclear Energy in Latin America and Caribbean
-
IAEA Joins Forces With Six Industry Partners to Close Global Cancer Care Divide
-
IAEA’s Rays of Hope Raises Over €100 Million to Bring Cancer Care Within Reach
Google News